-
公开(公告)号:US07928255B2
公开(公告)日:2011-04-19
申请号:US11585501
申请日:2006-10-23
IPC分类号: C07C57/00
CPC分类号: C07D317/72 , A61K31/202 , A61K31/216 , C07C59/68 , C07C59/70 , C07C69/708 , C07C69/736 , C07C209/68 , C07C217/46 , C07C229/12 , C07C235/06 , C07C323/52 , C07D317/22
摘要: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
摘要翻译: 本发明涉及下述式(I)和(II)的脂氧素A4类似物:其中R1,R2,R3,R4和R5如本文所述。 这些类似物可用于治疗人类的炎性和自身免疫性疾病。 这些类似物也可用于治疗人类的肺或呼吸道炎症。
-
公开(公告)号:US20070037864A1
公开(公告)日:2007-02-15
申请号:US11585501
申请日:2006-10-23
IPC分类号: A61K31/426 , A61K31/421 , A61K31/4166 , A61K31/365 , A61K31/135
CPC分类号: C07D317/72 , A61K31/202 , A61K31/216 , C07C59/68 , C07C59/70 , C07C69/708 , C07C69/736 , C07C209/68 , C07C217/46 , C07C229/12 , C07C235/06 , C07C323/52 , C07D317/22
摘要: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
摘要翻译: 本发明涉及下式(I)和(II)的脂氧素A 4 H 4类似物:其中R 1,R 2,R 2, 本文描述了第3和第4和第4和第5和第5。 这些类似物可用于治疗人类的炎性和自身免疫性疾病。 这些类似物也可用于治疗人类的肺或呼吸道炎症。
-
公开(公告)号:US06831186B2
公开(公告)日:2004-12-14
申请号:US10279084
申请日:2002-10-22
IPC分类号: A01N4376
CPC分类号: C07D317/72 , A61K31/202 , A61K31/216 , C07C59/68 , C07C59/70 , C07C69/708 , C07C69/736 , C07C209/68 , C07C217/46 , C07C229/12 , C07C235/06 , C07C323/52 , C07D317/22
摘要: This invention is directed to lipoxin A4 analogs of the following formula (I) and (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
摘要翻译: 本发明涉及下述式(I)和(II)的脂氧素A4类似物:其中R 1,R 2,R 3,R 4和R 5如本文所述。 这些类似物可用于治疗人类的炎性和自身免疫性疾病。 这些类似物也可用于治疗人类的肺或呼吸道炎症。
-
公开(公告)号:US07223798B2
公开(公告)日:2007-05-29
申请号:US10782024
申请日:2004-02-18
IPC分类号: A01N37/00
CPC分类号: C07D317/72 , A61K31/202 , A61K31/216 , C07C59/68 , C07C59/70 , C07C69/708 , C07C69/736 , C07C209/68 , C07C217/46 , C07C229/12 , C07C235/06 , C07C323/52 , C07D317/22
摘要: This invention is directed to lipoxin A4 analogs of the following formula (II): wherein R1, R2, R3, R4 and R5 are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
摘要翻译: 本发明涉及下式(II)的脂氧素A 4类似物:其中R 1,R 2,R 3,R 3, 本文描述了SUP> 4和R 5。 这些类似物可用于治疗人类的炎性和自身免疫性疾病。 这些类似物也可用于治疗人类的肺或呼吸道炎症。
-
-
-